Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 16: | Line 16: | ||
* Fareston - Generic: Toremifene | * Fareston - Generic: Toremifene | ||
* Nolvadex - Generic: Tamoxifen | * Nolvadex - Generic: Tamoxifen | ||
| - | =====Multiple Receptor Tyrosine Kinase ([[VEGFR]], PDGFR, KIT, Abl) Inhibitor===== | + | =====Multiple Receptor Tyrosine Kinase ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) Inhibitor===== |
* [[Gleevec]] - Generic: Imatinib | * [[Gleevec]] - Generic: Imatinib | ||
* [[Nexavar]] - Generic: Sorafenib | * [[Nexavar]] - Generic: Sorafenib | ||
| + | * Sprycel - Generic: Dasatinib | ||
* [[Sutent]] - Generic: Sunitinib | * [[Sutent]] - Generic: Sunitinib | ||
* Tasigna - Generic: Nilotinib | * Tasigna - Generic: Nilotinib | ||
Revision as of 16:03, 10 December 2010
Anti-CD20 Monoclonal Antibody
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Antagonist
Multiple Receptor Tyrosine Kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
